KarmanosHemeOnc Profile Banner
Karmanos Hematology/Oncology Fellowship Profile
Karmanos Hematology/Oncology Fellowship

@KarmanosHemeOnc

Followers
314
Following
343
Media
33
Statuses
262

Official Twitter page for the Hematology/Oncology Fellowship Program at Karmanos Cancer Institute/Wayne State University/Detroit Medical Center

Detroit, MI
Joined August 2022
Don't wanna be here? Send us removal request.
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
3 years
Join us to know more about our awesome Hematology/Oncology fellowship program at Karmanos Cancer Institute!!!.
0
0
2
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @richaparikh36: Thrilled to share that I have been selected as one among 25 junior faculty for the prestigious 2024 AACR/ASCO Methods in….
0
9
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @richaparikh36: Graduated from HemeOnc fellowship ⁦⁦@KarmanosHemeOnc⁩. The end of a 16yr long journey, filled with challenges and reward….
0
7
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @abdulmoiz92: Nothing is more satisfying than celebrating a milestone in the presence of family. So many people and forces have made me….
0
3
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
Presenting class of 2024👏🏽👏🏽Hearty congratulations to our freshly minted Hematologists/Oncologists, @MariaLevitinMD @JaneChi118308 @abdulmoiz92 @richaparikh36. We are so excited to see the incredible contributions you all will make to the field of Oncology in the years to come!
Tweet media one
Tweet media two
2
3
26
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @drtulsijose: #MedEd🤠@hemeoncfellow is looking for NEW #mentors. We paired 75 #Hemeonc fellowship aspirants in #match2025 with a fellow.….
0
4
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @Amyloid_Planet: Know what I love most about this paper? Not the high ORR & low CRS rate w Linvoseltamab for RRMM (though these are impr….
Tweet card summary image
ascopubs.org
PURPOSEWe present a phase I/II first-in-human trial evaluating the safety and efficacy of 50 mg and 200 mg doses of linvoseltamab, a B-cell maturation antigen × CD3 bispecific antibody in relapsed/...
0
1
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @vijsinghmd: 1/🧵 Why I'm skeptical about Imetelstat's use for MDS treatment:.Imetelstat is an oligonucleotide that inhibits telomerase a….
0
13
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
2
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
1
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
RT @IvyLorena_Md: I am deeply grateful for the time and effort the Next Wave Investigators in Thoracic Oncology Faculty have invested in me….
0
8
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
1
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
1
0
@KarmanosHemeOnc
Karmanos Hematology/Oncology Fellowship
1 year
0
1
0